IS2435B - Lyfjafræðileg loftúðasamsetning - Google Patents

Lyfjafræðileg loftúðasamsetning

Info

Publication number
IS2435B
IS2435B IS4974A IS4974A IS2435B IS 2435 B IS2435 B IS 2435B IS 4974 A IS4974 A IS 4974A IS 4974 A IS4974 A IS 4974A IS 2435 B IS2435 B IS 2435B
Authority
IS
Iceland
Prior art keywords
aerosol composition
pharmaceutical aerosol
pharmaceutical
composition
aerosol
Prior art date
Application number
IS4974A
Other languages
English (en)
Other versions
IS4974A (is
Inventor
Lewis David
Ganderton Davis
Meakin Brian
Ventura Paolo
Brambilla Gaetano
Garzia Raffaella
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2435(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of IS4974A publication Critical patent/IS4974A/is
Publication of IS2435B publication Critical patent/IS2435B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4974A 1997-06-13 1999-02-11 Lyfjafræðileg loftúðasamsetning IS2435B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (2)

Publication Number Publication Date
IS4974A IS4974A (is) 1999-02-11
IS2435B true IS2435B (is) 2008-10-15

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4974A IS2435B (is) 1997-06-13 1999-02-11 Lyfjafræðileg loftúðasamsetning

Country Status (45)

Country Link
EP (2) EP1219293A3 (is)
JP (1) JP4380802B2 (is)
KR (1) KR100546239B1 (is)
CN (1) CN1138532C (is)
AR (1) AR012977A1 (is)
AT (1) ATE222751T1 (is)
AU (1) AU729966B2 (is)
BG (1) BG63906B1 (is)
BR (1) BR9805993B1 (is)
CA (1) CA2263445C (is)
CO (1) CO4940408A1 (is)
CZ (1) CZ295521B6 (is)
DE (1) DE69807420T3 (is)
DK (1) DK0920302T4 (is)
DZ (1) DZ2516A1 (is)
EA (1) EA001259B1 (is)
EE (1) EE03664B1 (is)
ES (1) ES2182351T5 (is)
GB (1) GB2326334A (is)
GE (1) GEP20012462B (is)
HK (1) HK1022271A1 (is)
HR (1) HRP980317B1 (is)
HU (1) HU228487B1 (is)
ID (1) ID21491A (is)
IL (1) IL128484A (is)
IN (1) IN189317B (is)
IS (1) IS2435B (is)
IT (1) IT1293803B1 (is)
MA (1) MA26507A1 (is)
ME (2) MEP44008A (is)
MY (1) MY119074A (is)
NO (1) NO327775B1 (is)
NZ (1) NZ334149A (is)
PL (1) PL193721B1 (is)
PT (1) PT920302E (is)
RS (1) RS51274B (is)
SA (1) SA98190821B1 (is)
SI (1) SI0920302T2 (is)
SK (1) SK284430B6 (is)
TN (1) TNSN98087A1 (is)
TR (1) TR199900288T1 (is)
TW (1) TW555570B (is)
UA (1) UA70289C2 (is)
WO (1) WO1998056349A1 (is)
ZA (1) ZA985136B (is)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
GB2354007B (en) 1999-09-11 2003-10-22 Glaxo Group Ltd Pharmaceutical formulation of fluticasone propionate
EP1523976A3 (en) * 1999-11-23 2005-06-22 Glaxo Group Limited Pharmaceutical formulations of salmeterol
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
DZ3358A1 (fr) * 2000-05-22 2001-11-29 Chiesi Farma Spa Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
DK1273292T3 (da) 2001-07-02 2004-10-04 Chiesi Farma Spa Optimeret tobramycinformulering til aerosoldannelse
ES2745064T3 (es) 2002-03-01 2020-02-27 Chiesi Farm Spa Formulación superfina de formoterol
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
WO2004071488A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
MXPA05009920A (es) * 2003-03-20 2005-11-04 Boehringer Ingelheim Pharma Formulacion para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores.
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1809243B2 (de) 2004-07-02 2022-06-08 Boehringer Ingelheim International GmbH Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2217278A1 (en) * 2007-11-07 2010-08-18 AstraZeneca AB Dry powder formulations comprising ascorbic acid derivates
KR101798691B1 (ko) * 2010-09-06 2017-11-16 키에시 파르마슈티시 엣스. 피. 에이. 계량된-투여량 흡입기 및 계량된-투여량 흡입기의 사용 방법
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2017167737A1 (en) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
EP3515451B2 (en) * 2016-09-19 2023-10-04 Mexichem Fluor S.A. de C.V. Pharmaceutical composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005210A1 (en) † 1986-03-10 1987-09-11 Kurt Burghart Pharmaceutical preparation and process for preparing the same
WO1987005211A1 (en) † 1986-03-10 1987-09-11 Kurt Burghart Pharmaceutical preparation and process for producing the same
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DE69105212T2 (de) † 1990-10-18 1995-03-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69233150T2 (de) † 1991-06-10 2004-06-24 Schering Corp. Fluorchlorkohlenwasserstoffreie Aerosolformulierungen
ATE203900T1 (de) † 1991-06-10 2001-08-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
EP0616525B1 (en) * 1991-12-12 1995-09-27 Glaxo Group Limited Pharmaceutical aerosol formulation
DE69232034T2 (de) * 1991-12-18 2002-06-06 Minnesota Mining And Mfg. Co., Saint Paul Aerosolzusammensetzungen für Arzneimittelsuspensionen
WO1994013262A1 (en) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
AU700162B2 (en) † 1994-05-13 1998-12-24 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
EP1011646B1 (en) † 1996-12-04 2005-08-17 Link Products Limited Pharmaceutical compositions and devices for their administration
CA2280099C (en) † 1997-02-05 2005-12-27 Jago Pharma Ag Medical aerosol formulations

Also Published As

Publication number Publication date
EP0920302A1 (en) 1999-06-09
AU8626298A (en) 1998-12-30
ES2182351T5 (es) 2007-03-16
CA2263445C (en) 2008-09-09
ES2182351T3 (es) 2003-03-01
SI0920302T2 (sl) 2006-10-31
MY119074A (en) 2005-03-31
SA98190821B1 (ar) 2006-11-19
JP4380802B2 (ja) 2009-12-09
DK0920302T4 (da) 2006-10-09
DE69807420T2 (de) 2003-05-08
MEP44008A (en) 2011-02-10
PL193721B1 (pl) 2007-03-30
EE03664B1 (et) 2002-04-15
UA70289C2 (uk) 2004-10-15
ITMI971798A1 (it) 1999-01-28
EP0920302B1 (en) 2002-08-28
EP1219293A2 (en) 2002-07-03
PT920302E (pt) 2002-11-29
RS51274B (sr) 2010-12-31
AR012977A1 (es) 2000-11-22
CN1229355A (zh) 1999-09-22
EP1219293A3 (en) 2003-05-28
CZ46299A3 (cs) 1999-07-14
ME00333B (me) 2011-02-10
TR199900288T1 (xx) 1999-09-21
YU6999A (sh) 2000-03-21
AU729966B2 (en) 2001-02-15
BG103221A (en) 1999-09-30
NZ334149A (en) 2000-07-28
SK284430B6 (sk) 2005-04-01
IT1293803B1 (it) 1999-03-10
DZ2516A1 (fr) 2004-11-08
EA001259B1 (ru) 2000-12-25
HUP0001339A2 (hu) 2000-09-28
HRP980317A2 (en) 1999-04-30
BR9805993B1 (pt) 2009-05-05
EE9900055A (et) 1999-08-16
GEP20012462B (en) 2001-06-25
HRP980317B1 (en) 2002-06-30
IS4974A (is) 1999-02-11
GB9712434D0 (en) 1997-08-13
NO990594L (no) 1999-04-13
PL331531A1 (en) 1999-07-19
IN189317B (is) 2003-02-08
CZ295521B6 (cs) 2005-08-17
HK1022271A1 (en) 2000-08-04
IL128484A0 (en) 2000-01-31
EP0920302B2 (en) 2006-06-21
ZA985136B (en) 1999-01-07
DE69807420D1 (de) 2002-10-02
TNSN98087A1 (fr) 2005-03-15
ID21491A (id) 1999-06-17
CN1138532C (zh) 2004-02-18
EA199900201A1 (ru) 1999-06-24
MA26507A1 (fr) 2004-12-20
JP2000516965A (ja) 2000-12-19
KR100546239B1 (ko) 2006-01-26
IL128484A (en) 2004-09-27
NO327775B1 (no) 2009-09-21
SK17699A3 (en) 1999-07-12
TW555570B (en) 2003-10-01
SI0920302T1 (en) 2002-12-31
BR9805993A (pt) 1999-08-31
NO990594D0 (no) 1999-02-09
GB2326334A (en) 1998-12-23
KR20000068171A (ko) 2000-11-25
DE69807420T3 (de) 2006-11-16
HU228487B1 (en) 2013-03-28
DK0920302T3 (da) 2002-12-23
BG63906B1 (bg) 2003-06-30
ATE222751T1 (de) 2002-09-15
CA2263445A1 (en) 1998-12-17
WO1998056349A1 (en) 1998-12-17
HUP0001339A3 (en) 2000-10-30
CO4940408A1 (es) 2000-07-24

Similar Documents

Publication Publication Date Title
DK0920302T4 (da) Farmaceutisk aerosolsammensætning
DK1073417T3 (da) Farmaceutisk aerosolformulering
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
DE69530325D1 (de) Aerosol-arzneiformulierungen
ID24654A (id) Formulasi farmasi omeprazola
ID18352A (id) Komposisi-komposisi farmasi
EE9900545A (et) Farmatseutiline kompositsioon
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ID18698A (id) Komposisi farmasi
ITMI962628A0 (it) Composizione farmaceutica
ID23531A (id) Komposisi farmasi
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
BR1100755A (pt) composição farmacêutica
BR1101151A (pt) Compostos e composição farmacêutica
ID17133A (id) Komposisi farmasi
SE9601854D0 (sv) Farmaceutisk komposition
SE9604299D0 (sv) Pharmaceutical composition